Department of Health
and Human Services (HHS)
and Human Services (HHS)
August 19, 2021
PAR-21-247 - Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
RFA-HG-21-001 - Technology Development for Single-Molecule Protein Sequencing and Single-Cell Proteome Analysis (R01 Clinical Trial not allowed)
RFA-HG-21-002 - Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed)
National Human Genome Research Institute (NHGRI)
The purpose of this Notice is to inform applicants of a correction to the Open Date (Earliest Submission Date) for Funding Opportunity Announcement (FOA) PAR-21-247, “Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)". This FOAhas been changed to show that the first Open Date for application submission is September 1, 2021.
The following section of PAR-21-247 has been modified:
Currently Reads:
Key Dates
Posted Date
July 9, 2021
Open Date (Earliest Submission Date)
October 1, 2021
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
October 1, 2021; June 15, 2022; June 15, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
February/March 2022; October/November 2022; October/November 2023
Advisory Council Review
May 2022; February 2023; February 2024
Earliest Start Date
August 2022; May 2023; May 2024
Expiration Date
June 16, 2023
Due Dates for E.O. 12372
Not Applicable
Modified to Read (change shown in bold italics):
Key Dates
Posted Date
July 9, 2021
Open Date (Earliest Submission Date)
September 1, 2021
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
October 1, 2021; June 15, 2022; June 15, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
February/March 2022; October/November 2022; October/November 2023
Advisory Council Review
May 2022; February 2023; February 2024
Earliest Start Date
August 2022; May 2023; May 2024
Expiration Date
June 16, 2023
Due Dates for E.O. 12372
Not Applicable
All other aspects of this FOA remain unchanged.
Tina Gatlin, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2280
Email: [email protected]